Skip to content

Study on the Biological Prediction Models of Radiation Pneumonitis

Study on the Biological Prediction Models of Radiation Pneumonitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02490319
Enrollment
300
Registered
2015-07-03
Start date
2008-09-30
Completion date
Unknown
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Pneumonitis

Keywords

radiation pneumonitis, lung cancer, prediction models, genetic variants

Brief summary

Radiation pneumonitis is the most common complication and the major dose-limiting toxicity associated with radiotherapy, which can cause poor quality of life or life-threatening symptoms and might hinder the tumor-controlling effects of radiotherapy. Consequently, establishing reliable predictors for the occurrence of RP is of great significance such that the therapeutic effects of RT can be maximized while minimizing its adverse effects. The aim of this study is to figure out the biological prediction models of radiation pneumonitis.

Detailed description

1. Establish a clinical data base for the lung cancer patients treated with radiotherapy in Tongji Hospital. Data including age, gender, smoking state, KPS, pulmonary function, disease history, histology, stage, surgery, chemotherapy, dosimetric parameters of radiotherapy were collected. Peripheral blood was collected from all patients enrolled. All patients enrolled in this study are examined during and one month after radiotherapy. Then, the patients are followed every three months for the first year and every six months thereafter. At each follow-up visits, all patients are asked to undergo a chest X-ray or CT and clinical information, including symptoms, is collected. RP is graded by two radiation oncologists according to the Common Terminology Criteria for Adverse Events 4.0. 2. Select candidate genes and pathways which may be associated with radiation pneumonitis and identify their tagSNPs by Haploview. 3. Use Kaplan-Meier and Cox model to analyze the association of all the factors collected with radiation pneumonitis. 4. Establish a biological prediction models for radiation pneumonitis based on the statistics analysis

Interventions

None listed

Sponsors

Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Clinical diagnosis of lung cancer by histology 2. Radiation dose at least 45 Gy 3. KPS\>60 4. Life expectancy of at least 6 months 5. Voluntarily signed the informed consent

Exclusion criteria

1. Previous thoracic irradiation 2. Severe cardiopulmonary diseases

Design outcomes

Primary

MeasureTime frame
radiation pneumonitis grade >=2 or 312 months after radiotherapy

Countries

China

Contacts

Primary ContactXianglin Yuan, MD, PhD
yxl@medmail.com.cn13667241722
Backup ContactYang Tang, MD, PhD
tangyangtjmu@126.com18627182062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026